Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Ultrasound Increases Diagnostic Certainty of PsA Diagnosis

Preliminary findings of the PREDICT study suggest that the DUET Ultrasound Enthesitis Score may improve the confidence with which rheumatologists can diagnose psoriatic arthritis.

Adjuvant Radiotherapy Use Lags in Localized Merkel Cell

Adjuvant radiation therapy use has risen slightly overall in Merkel cell carcinoma but not for localized disease, study shows.

Italian Panel Pushes Biosimilars for IMID Care

An Italian expert panel is urging broader biosimilar use, faster access to new therapies, and stronger real-world tracking to improve sustainable care for inflammatory diseases.

Can Hypothalamic Damage Trigger Obesity

Hypothalamic damage disrupts hunger and satiety regulation, causing rapid weight gain, which often responds poorly to conventional lifestyle interventions.

Canada Wildfire Smoke Blankets US Midwest, Northeast

Heavy smoke from hundreds of wildfires in Canada enveloped a swath of the U.S. from the Midwest to the Northeast on Thursday, prompting warnings that residents should stay indoors.

Tissue Micro-Coring Improves Lower-Face Wrinkles

Tissue micro-coring improved the appearance of nasolabial folds, marionette lines, and perioral wrinkles in a small real-world study.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

Preliminary findings of the PREDICT study suggest that the DUET Ultrasound Enthesitis Score may improve the confidence with which rheumatologists can diagnose psoriatic arthritis.

Adjuvant radiation therapy use has risen slightly overall in Merkel cell carcinoma but not for localized disease, study shows.

An Italian expert panel is urging broader biosimilar use, faster access to new therapies, and stronger real-world tracking to improve sustainable care for inflammatory diseases.

Hypothalamic damage disrupts hunger and satiety regulation, causing rapid weight gain, which often responds poorly to conventional lifestyle interventions.

Heavy smoke from hundreds of wildfires in Canada enveloped a swath of the U.S. from the Midwest to the Northeast on Thursday, prompting warnings that residents should stay indoors.

Tissue micro-coring improved the appearance of nasolabial folds, marionette lines, and perioral wrinkles in a small real-world study.

News All Time

Panel Provides Consensus for Standardizing CSCC Imaging

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.

Unapproved Peptides Common in Australia Despite Crackdown

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

FPT Plus Pulsed Dye Laser Effective for Port-Wine Birthmarks

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Skin Cancer: 5 Practical Tips for Earlier Detection

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

Dermatology AI Is Here. Now Comes the Hard Part

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Tumor Biomarker Improves Surveillance of MCC Recurrences

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Candida auris Infections Persist, CDC Report Shows

Clinical and screening cases of C auris doubled between 2022 and 2024.

Patient Engagement With Dermatology Visit Notes Remains Low

Patient engagement with dermatology notes in the electronic patient portal varies by language, race, ethnicity, and clinician factors, study shows.

The Newest Frontier for GLP-1s: Clearing Skin Disease

Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly.

Strange Asymptomatic Rash Affects Young Man With Obesity for 2 Years

Diagnosis implicates high triglycerides as a contributor

Ambulatory Surgery May Be an Option for Troublesome HS

A wave of recently approved therapies has improved options for the control of hidradenitis suppurativa, but surgery remains a possible option for faster clinical benefit.

People With Atopic Eczema Stick With Dupilumab Longer

Real-world data shows dupilumab had higher 1-year treatment continuation than oral or subcutaneous methotrexate and ciclosporin.

Skip the Stairs: The Elevator Approach to Psoriasis

Rheumatologists and gastroenterologists don’t save their best drugs until last; neither should dermatologists.

Detecting Hidradenitis Suppurativa: Bringing the Patient's Voice to the Forefront

Detecting Hidradenitis Suppurativa: Bringing the Patient's Voice to the Forefront

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

Recommended News For You

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

Study shows virtual reality headsets may help ease cancer pain

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes 

Intratumoral Drug Distribution as a Determinant of Therapeutic Success 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The discovery of drug combinations may increase the life expectancy of children with brain cancer.

2.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

3.

High levels of traumatic stress found in caregivers of adult cancer patients

4.

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

5.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

1.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

2.

Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights

3.

Progressive Updates in Oncology for Healthcare Excellence

4.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

5.

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

2.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

3.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot